Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib and Ritonavir in Chronic Hepatitis D Virus Infection
NCT05229991Phase 3Completed
- Sponsor
- Soroka University Medical Center
- Start
- May 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of lonafarnib in chronic hepatitis D, sponsored by Soroka University Medical Center. Started May 2021; status: completed.
02
Drugs
lonafarnib
03
Conditions
chronic hepatitis D
Beyond the preview
Go deeper on NCT05229991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229991.